Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Triple Negative Breast Neoplasms 2Non-squamous Non-small-cell Lung Cancer 1Non Squamous Non Small Cell Lung 1Neoadjuvant Therapy 1Gastrointestinal Stromal Tumors 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced NSCLC 1

Interventions

famitinib 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Non Squamous Non Small Cell Lung × famitinib × Clear all
NCT02766140 2019-01-18

SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 3 Terminated
12 enrolled
Thoracic

Non Squamous Non Small Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡